Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a custom tumor map guide better ovarian cancer care?

NCT ID NCT06466382

Recruiting now Knowledge-focused Sponsor: Swiss GO Trial Group Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This Swiss study is testing whether creating a detailed molecular profile of each patient's tumor can help doctors choose more effective treatments for advanced ovarian cancer. Sixty newly diagnosed patients will be randomly assigned to either standard care or a personalized treatment plan recommended by a molecular tumor board. The goal is to see if this tailored approach leads to better tumor response and helps doctors feel more confident in their treatment decisions.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
molecular tumor board recommendation based on tumor profiling
What this could lead to
If successful, this could show that personalized treatment plans based on detailed tumor analysis improve outcomes for ovarian cancer patients who don't respond to standard therapy.
What could go wrong
This is a small pilot study (60 participants) focused on feasibility and early signals, not a large-scale test of effectiveness. The approach may not lead to better survival or quality of life.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARCINOSARCOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

carcinosarcoma fallopian tube neoplasm ovarian endometrioid adenocarcinoma ovarian epithelial tumor ovarian serous adenocarcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

FALLOPIAN TUBE NEOPLASMS HIGH-GRADE SEROUS OVARIAN CARCINOMA (HGSOC) OVARIAN ENDOMETRIOID CARCINOMA OVARIAN NEOPLASM EPITHELIAL

Contacts and locations

Locations

  • HFR-Fribourg- Hopital Cantonal

    RECRUITING

    Fribourg, 1708, Switzerland

  • HOCH Health Ostschweiz Kantonsspital St.Gallen

    RECRUITING

    Sankt Gallen, Canton of St. Gallen, 9007, Switzerland

  • Inselspital Bern (University Hospital for Medical Oncology)

    RECRUITING

    Bern, 3010, Switzerland

  • Kantonsspital Baden AG

    RECRUITING

    Baden, Canton of Aargau, 5404, Switzerland

  • Thurgau AG Frauenfeld / Münsterlingen

    RECRUITING

    Frauenfeld, Thurgau, 8500, Switzerland

  • University Hospital Zurich

    RECRUITING

    Zurich, 8091, Switzerland

  • Universitätsspital Basel

    RECRUITING

    Basel, Canton of Basel-City, 4031, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.